Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 106    |    Report Code: BMIRE00029253    |    Category: Life Sciences

Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market

亚太地区荧光原位杂交 (FISH) 成像系统市场预计将从 2022 年的 2.176 亿美元增长到 2030 年的 4.009 亿美元。预计复合年增长率为 7.9 % 从 2022 年到 2030 年。

体外诊断不断增加的研发投资推动亚太荧光原位杂交 (FISH) 成像系统市场

亚太地区荧光原位杂交 (FISH) 成像系统市场是由体外诊断 (IVD) 相关研发 (R&D) 活动的持续投资推动的。凭借其在细胞环境中可视化特定 DNA 序列的独特能力,FISH 技术已成为现代诊断生态系统中的关键程序,特别是在检测遗传性疾病和罕见疾病方面。 IVD 研发资金的激增促进了 FISH 成像系统的变革性进步,研究人员能够创建尖端平台,提供增强的图像质量和支持简化自动化的功能,最终实现更准确、更快速的诊断过程。 PNA FISH 是一种使用 FISH 结合肽核酸 (PNA) 探针的新型诊断方法,将传统染色程序的简便性与 PNA 探针的卓越性能相结合,可快速、准确地诊断传染病,这使得 PNA FISH 适合常规检测使临床微生物学实验室能够在使用传统生化方法无法实现的时间范围内报告患者治疗的重要信息。

亚太荧光原位杂交 (FISH) 成像系统市场概览

亚太地区荧光原位杂交 (FISH) 成像系统市场预计在预测期内复合年增长率最高。由于各国癌症患病率较高、政府改善医疗器械行业的举措以及稳健的医疗器械制造等因素,预计该区域市场在未来几年将快速增长。印度尼西亚、印度和中国的交付中心通常支持该地区的外包服务。此外,遗传性疾病和传染病病例的增加显着扩大了亚太地区荧光原位杂交 (FISH) 成像系统市场的增长。

亚太地区荧光原位杂交 (FISH) 成像系统市场的增长。 FISH)成像系统市场收入及2030年预测(百万美元)

亚太地区荧光原位杂交(FISH)成像系统市场细分

亚太地区荧光原位杂交 (FISH) 成像系统市场分为产品、应用、最终用户和国家/地区。

根据产品,亚太地区荧光原位杂交 (FISH) 成像系统市场分为产品、应用、最终用户和国家/地区。 (FISH)成像系统市场分为仪器、耗材、配件和软件。 2022年,耗材领域在亚太荧光原位杂交(FISH)成像系统市场中占据最大份额。

从应用来看,亚太荧光原位杂交(FISH)成像系统市场细分为癌症诊断、遗传病诊断、传染病诊断等。 2022年,癌症诊断领域在亚太荧光原位杂交(FISH)成像系统市场中占据最大份额。

根据最终用户,亚太荧光原位杂交(FISH)成像系统市场分为诊断实验室、合同研究组织、制药和生物技术公司等。 2022 年,诊断实验室领域在亚太地区荧光原位杂交 (FISH) 成像系统市场中占据最大份额。

按国家/地区划分,亚太地区荧光原位杂交 (FISH) 成像系统市场分为中国、日本、印度、韩国、澳大利亚和亚太其他地区。 2022 年,中国将主导亚太地区荧光原位杂交 (FISH) 成像系统市场。

Euroclone SpA、Tissuegnostics Gmbh、安捷伦科技公司、Abnova 台湾公司、Biogenex Laboratories Inc、Leica Biosystems Nussloch Gmbh、 Metasystems Probes Gmbh、Bio-View Ltd 和 Thermo Fisher Scientific Inc 是亚太地区荧光原位杂交 (FISH) 成像系统市场的领先公司。   



Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Strategic Insights

Strategic insights for Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-fluorescence-in-situ-hybridization-fish-imaging-systems-market-strategic-framework.webp
Get more information on this report

Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Report Scope

Report Attribute Details
Market size in 2022 US$ 217.6 Million
Market Size by 2030 US$ 400.9 Million
Global CAGR (2022 - 2030) 7.9%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 产品
  • 仪器
  • 耗材
  • 配件
  • 软件
By 应用
  • 癌症诊断
  • 遗传病诊断
  • 传染病诊断
By 最终用户
  • 诊断实验室
  • 合同研究组织
  • 制药和生物技术公司
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Euroclone SpA
  • TissueGnostics GmbH
  • Agilent Technologies Inc
  • Abnova Taiwan Corp
  • BioGenex Laboratories Inc
  • Leica Biosystems Nussloch GmbH
  • MetaSystems Probes GmbH
  • Bio-View Ltd
  • Thermo Fisher Scientific Inc
  • Applied Spectral Imaging
  • Get more information on this report

    Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Regional Insights

    The regional scope of Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-fluorescence-in-situ-hybridization-fish-imaging-systems-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market

    • Euroclone SpA
    • TissueGnostics GmbH
    • Agilent Technologies Inc
    • Abnova Taiwan Corp
    • BioGenex Laboratories Inc
    • Leica Biosystems Nussloch GmbH
    • MetaSystems Probes GmbH
    • Bio-View Ltd
    • Thermo Fisher Scientific Inc
    • Applied Spectral Imaging
    Frequently Asked Questions
    How big is the Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market?

    The Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market is valued at US$ 217.6 Million in 2022, it is projected to reach US$ 400.9 Million by 2030.

    What is the CAGR for Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market by (2022 - 2030)?

    As per our report Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, the market size is valued at US$ 217.6 Million in 2022, projecting it to reach US$ 400.9 Million by 2030. This translates to a CAGR of approximately 7.9% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market report typically cover these key segments-

  • 产品 (仪器, 耗材, 配件, 软件)
  • 应用 (癌症诊断, 遗传病诊断, 传染病诊断)
  • 最终用户 (诊断实验室, 合同研究组织, 制药和生物技术公司)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market?

    The Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Euroclone SpA
  • TissueGnostics GmbH
  • Agilent Technologies Inc
  • Abnova Taiwan Corp
  • BioGenex Laboratories Inc
  • Leica Biosystems Nussloch GmbH
  • MetaSystems Probes GmbH
  • Bio-View Ltd
  • Thermo Fisher Scientific Inc
  • Applied Spectral Imaging
  • Who should buy this report?

    The Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market value chain can benefit from the information contained in a comprehensive market report.